Aegerion gets DOJ subpoena over marketing of cholesterol drug
(Reuters) – Aegerion Pharmaceuticals Inc said on Thursday that it received a subpoena from the U.S. Department of Justice, requesting documents related to the marketing and sale of its cholesterol…